Hepatitis B Immune Globulin Completed Phase 3 Trials for Viral Hepatitis B / Transplantation, Liver Prevention

IndicationsStatusPurposePhase
CompletedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT01131065Efficacy and Safety of Niuliva® for the Prevention of Hepatitis B Virus Recurrence in Newly Orthotopic Liver Transplant Recipients
NCT01856413A Clinical Trial of Zutectra in Patients Who Recently Received a Liver Transplant